Loading...

Morphic Holding, Inc.

MORFNASDAQ
Healthcare
Biotechnology
$56.99
$0.02(0.04%)

Morphic Holding, Inc. (MORF) Stock Overview

Explore Morphic Holding, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 63.2/100

Key Financials

Market Cap2.9B
P/E Ratio-19.88
EPS (TTM)$-3.83
ROE-0.22%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$28.60

MORF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Morphic Holding, Inc. (MORF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $28.60.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -19.88 and a market capitalization of 2.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;